We are live on ! Find out more
AG

Artal Group Portfolio holdings

AUM $931M
1-Year Est. Return 41.63%
This Fund
S&P 500
This Quarter Est. Return
-15.88%
1 Year Est. Return
+41.63%
3 Year Est. Return
+181.18%
5 Year Est. Return
+113.34%
10 Year Est. Return
+1,823.73%
AUM
$4.48B
AUM Growth
+$2.15B
Cap. Flow
+$2.73B
Cap. Flow %
60.98%
Top 10 Hldgs %
76.84%
Holding
89
New
19
Increased
22
Reduced
9
Closed
13

Top Buys

Rank Stock Value
1
BUFF
Blue Buffalo Pet Products, Inc
BUFF
+$2.82B
2
BLUE
bluebird bio
BLUE
+$16.2M
3
YUM icon
Yum! Brands
YUM
+$12.6M
4
MS icon
Morgan Stanley
MS
+$9.1M
5
AGIO icon
Agios Pharmaceuticals
AGIO
+$6.35M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$32.9M
2
MBLY
Mobileye N.V.
MBLY
+$26.6M
3
AER icon
AerCap
AER
+$17.2M
4
AAL icon
American Airlines Group
AAL
+$16M
5
BABA icon
Alibaba
BABA
+$14.5M

Sector Composition

Rank Sector Weight
1 Consumer Staples 46.01%
2 Miscellaneous 26.09%
3 Healthcare 20.53%
4 Consumer Discretionary 5.21%
5 Financials 1.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BUFF
1
DELISTED
Blue Buffalo Pet Products, Inc
BUFF
$2.06B 46.01%
+114,987,547
New +$2.82B
LXRX icon
2
Lexicon Pharmaceuticals
LXRX
$881M
$618M 13.8%
57,517,978
– –
WW
3
DELISTED
WW International
WW
$188M 4.2%
29,443,300
– –
BIIB icon
4
CALL
Biogen
BIIB
$32.1B
$117M 2.61%
400,000
+50,000
+14% +$16.5M
WMT icon
5
CALL
Walmart Inc
WMT
$865B
$108M 2.41%
4,995,000
– –
GS icon
6
CALL
Goldman Sachs
GS
$288B
$86.9M 1.94%
500,000
+200,000
+67% +$39.2M
JPM icon
7
CALL
JPMorgan Chase
JPM
$931B
$79.3M 1.77%
1,300,000
+700,000
+117% +$45.8M
CELG
8
CALL
DELISTED
Celgene Corp
CELG
$70.3M 1.57%
650,000
+50,000
+8% +$6.2M
MET icon
9
CALL
MetLife
MET
$61.7B
$58.9M 1.32%
1,402,500
+729,300
+108% +$34.1M
INCY icon
10
Incyte
INCY
$24.8B
$54.1M 1.21%
490,000
+10,000
+2% +$1.12M
GE icon
11
CALL
GE Aerospace
GE
$329B
$50.4M 1.13%
417,324
– –
BAC icon
12
CALL
Bank of America
BAC
$416B
$46.7M 1.04%
3,000,000
+500,000
+20% +$8.41M
BMRN icon
13
BioMarin Pharmaceuticals
BMRN
$12.9B
$46.3M 1.04%
440,000
+5,000
+1% +$668K
GOOG icon
14
CALL
Alphabet (Google) Class C
GOOG
$4.23T
$36.5M 0.82%
1,200,000
-3,300,000
-73% -$101M
ALNY icon
15
Alnylam Pharmaceuticals
ALNY
$33.5B
$35M 0.78%
435,000
-20,000
-4% -$2.22M
ENDP
16
CALL
DELISTED
Endo International plc
ENDP
$34.6M 0.77%
+500,000
New +$40M
AXP icon
17
CALL
American Express
AXP
$221B
$33.4M 0.75%
450,000
– –
MS icon
18
CALL
Morgan Stanley
MS
$324B
$31.5M 0.7%
1,000,000
+250,000
+33% +$9.1M
GM icon
19
CALL
General Motors
GM
$76.5B
$30M 0.67%
1,000,000
– –
BMY icon
20
CALL
Bristol-Myers Squibb
BMY
$131B
$29.6M 0.66%
+500,000
New +$31.7M
BABA icon
21
CALL
Alibaba
BABA
$272B
$29.5M 0.66%
500,000
+400,000
+400% +$29.1M
GILD icon
22
CALL
Gilead Sciences
GILD
$182B
$29.5M 0.66%
300,000
+200,000
+200% +$22.2M
XBI icon
23
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.6B
$28M 0.63%
+450,000
New +$35.5M
C icon
24
CALL
Citigroup
C
$228B
$27.3M 0.61%
550,000
+150,000
+38% +$8.19M
MA icon
25
Mastercard
MA
$503B
$27M 0.6%
300,000
-100,000
-25% -$9.39M
1
2 3 4

Similar funds

BCM
Bronte Capital Management Bondi Junction, Australia $931M AUM 47.97% 1-Year Est. Return
ACM
Ashe Capital Management Englewood Cliffs, New Jersey $931M AUM 4.95% 1-Year Est. Return
SAM
Sycomore Asset Management Paris, France $932M AUM 51.25% 1-Year Est. Return
NS
Night Squared New York $930M AUM 56.46% 1-Year Est. Return
PA
Planning Alternatives Birmingham, Michigan $933M AUM 28.32% 1-Year Est. Return
ACM
Ashford Capital Management Wilmington, Delaware $933M AUM 56.2% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $929M AUM 53.07% 1-Year Est. Return
CAM
Claret Asset Management Montreal, Quebec, Canada $928M AUM 25.4% 1-Year Est. Return

Artal Group's Q3 2015 Portfolio in Review

As of Q3 2015, Artal Group held 89 positions worth $4.48B, up 93% from $2.32B the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Artal Group deployed $2.73B of net new capital in Q3 2015, opening 19 new positions and adding to 22 existing holdings. Its largest new stake was Blue Buffalo Pet Products, Inc: 114,987,547 shares worth $2.06B.

By sector, the portfolio is most concentrated in Consumer Staples at 46% of assets, up from 0% a quarter earlier, followed by Miscellaneous and Healthcare.

On the sell side, the largest reduction was Alibaba, an estimated $14.5M trimmed.

  • Artal Group's largest Q3 2015 buy was Blue Buffalo Pet Products, Inc: 114,987,547 shares worth $2.06B.
  • Artal Group added most to bluebird bio in Q3 2015, an estimated $16.2M increase.
  • Artal Group's biggest Q3 2015 reduction was Alibaba, cutting an estimated $14.5M.
  • Artal Group fully exited Amazon in Q3 2015, selling an estimated $32.9M.
  • Artal Group's ten largest holdings make up 77% of its $4.48B portfolio in Q3 2015.
  • Artal Group opened 19 new positions and closed 13 in Q3 2015.
  • Artal Group's portfolio value rose 93% quarter-over-quarter to $4.48B.

Based on Artal Group's 13F filing for Q3 2015, filed 13 Nov 2015.